11. Antithrombotic therapies

Six-month versus 12-month DAPT after DES

EXCELLENT
Objective
to report the adverse clinical outcomes of 6-month DAPT compared to 12 month DAPT
Study
multicentre, non-inferiority randomised trial
Population
patients receiving drug-eluting coronary stents
Endpoints
target vessel failure as composite of cardiac death, MI, or ischaemia-driven target vessel revascularisation at 12 months
Conclusion
Six-month DAPT after DES was non-inferior to 12-month DAPT
Gwon et al. Circulation 2023; November
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved